The Singapore Family Physician

Back to issue Vol 47 No. 8 - Updates in DM and CKD management: Are SGLT2 Inhibitors the answer?

How Can We Halt-CKD in Primary Care?: Clinical Care Paths to Manage Chronic Kidney Disease

Ooi Xi Yan
Yeo See Cheng
The Singapore Family Physician Vol 47 No 8 - Updates in DM and CKD management: Are SGLT2 Inhibitors the answer?
13 - 18
2 October 2021
0377-5305
Chronic kidney disease (CKD) is a major health problem in Singapore, and its incidence is projected to rise. Slowing the progression of CKD is paramount in enabling patients to live longer without complications or the need for kidney replacement therapy, allaying the health and economic burden of CKD on individuals and the society. Effective treatment strategies comprise of lifestyle, dietary and medical management, which include dietary sodium restriction, physical activity, smoking cessation, blood pressure and glucose control and use of renin-angiotensin system inhibitors to reduce albuminuria. The Holistic Approach in Lowering and Tracking Chronic Kidney Disease (HALT-CKD) programme is a concerted effort to delay the progression of CKD through a multi-faceted, integrated approach. Here, we outline the rationale and aims of these recommendations, provide practical tips for implementing these interventions and highlight future opportunities in our ongoing battle against CKD.